Safety and efficacy of calcitonin gene related polypeptide monoclonal antibodies (erenumab, fremanezumab and galcanezumab) in elderly patients with migraine
Latest Information Update: 16 Jul 2020
At a glance
- Drugs Erenumab (Primary) ; Fremanezumab (Primary) ; Galcanezumab (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- 16 Jul 2020 New trial record
- 20 Jun 2020 Results presented at the 62nd Annual Scientific Meeting of the American Headache Society